Yahoo Finance

Apricus Biosciences Receives Complete Response Letter from FDA for Vitaros(TM)

SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the U.S.
Daily Mail

Woman suffers chemical burns after being mistakenly prescribed ERECTILE DYSFUNCTION cream called Vitaros instead of dry eye lubricant Vita-POS

A woman inadvertently put erectile dysfunction cream into her eye after a mix-up over two medications with very similar names. The patient, whose name and age are unknown, ended up with redness, ...
Business Insider

Apricus Begins Discussions With Interested Parties For U.S. Vitaros Rights

(RTTNews) - Apricus Biosciences, Inc. (APRI) announced the outcome of its end-of-review meeting with the U.S. FDA on the New Drug Application for Vitaros (alprostadil), a topical cream for the ...
Yahoo Finance

Apricus Biosciences Announces Scheduling of Vitaros(TM) End-of-Review Meeting with FDA

SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that its ...
The Independent

Woman mistakenly prescribed with erectile dysfunction cream for dry eye suffers chemical injuries

A woman suffered chemical injuries after she was mistakenly prescribed erectile dysfunction cream for a severe dry eye. The anonymous patient, from Glasgow, had to be treated in A&E after she ...
Medscape

Topical ED Treatment Vitaros Approved in Europe

Apricus Biosciences has received European approval to market alprostadil 0.3% topical cream (Vitaros) for the treatment of erectile dysfunction (ED), the company announced today. Vitaros is a ...
Metro

Woman prescribed erectile dysfunction cream for her dry eye

A woman ended up in A&E after she was prescribed erectile dysfunction cream to treat a dry eye by mistake. The anonymous patient, from Glasgow, was given Vitaros cream instead of the eye lubricant ...
Yahoo Finance

Apricus Biosciences Announces Outcome of Vitaros(TM) End-of-Review Meeting with FDA

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the outcome of ...
Business Insider

Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA

Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Finanznachrichten

Apricus Biosciences, Inc.: Apricus Biosciences Announces Outcome of Vitaros End-of-Review Meeting with FDA

Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...